STVN logo

Stevanato Group S.p.A. (STVN)

$15.25

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on STVN

Market cap

$4.16B

EPS

0.6

P/E ratio

--

Price to sales

3.85

Dividend yield

0.41%

Beta

0.80468

Price on STVN

Previous close

$15.53

Today's open

$15.48

Day's range

$15.25 - $16.09

52 week range

$12.05 - $24.01

Profile about STVN

CEO

Franco Stevanato

Employees

6010

Headquarters

Piombino Dese, Padua

Exchange

New York Stock Exchange

Shares outstanding

273003694

Issue type

Common Stock

STVN industries and sectors

Healthcare

Biotechnology & Life Sciences

News on STVN

Stevanato Group to Participate in Upcoming Investor Conferences

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences. The Company will participate in the Jefferies Global Healthcare Conference taking place from Monday, November 16, 2026, to Thursday, November 19, 2026, in London. The Company will host a.

news source

Business Wire • Nov 16, 2026

news preview

STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $STVN--STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law.

news source

Business Wire • Nov 7, 2026

news preview

Stevanato Group Q3 Earnings Call Highlights

Stevanato Group NYSE: STVN reported third-quarter 2026 revenue growth of 8% to €326.1 million, supported by continued expansion in its biopharmaceutical and diagnostic solutions business despite weaker demand tied to GLP-1 therapies and a decline in its engineering segment.

news source

MarketBeat • Nov 4, 2026

news preview

Stevanato Group (STVN) Shareholder Investigation Following Stock Decline – Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of Stevanato Group (STVN) investors following the Company's stock price decline

news source

GlobeNewsWire • Nov 4, 2026

news preview

STVN INVESTOR ALERT: Investigation of Stevanato Group S.p.A. Announced by Holzer & Holzer, LLC

ATLANTA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Stevanato Group S.p.A. (“Stevanato” or the “Company”) (NYSE: STVN) complied with federal securities laws. On November 3, 2026, Stevanato reported third quarter 2026 financial results and on the accompanying earnings call revealed that “Revenue related to GLP-1s decreased in the third quarter and was approximately 17% to 18% of the total company revenue.” On this news, the price of the Company's stock dropped.

news source

GlobeNewsWire • Nov 4, 2026

news preview

Did You Lose Money on Stevanato Group S.p.A. Stock? The Law Offices of Howard G.

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Stevanato Group S.p.A. ("Stevanato" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Stevanato Group S.p.A. (NYSE: STVN) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 3, 2026 disclosure concerning Stevanato Group S.p.A.Inves.

news source

Business Wire • Nov 4, 2026

news preview

Lost Money on Stevanato Group S.p.A. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 28.57% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Stevanato Group S.p.A. ("Stevanato" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Stevanato Group S.p.A. (NYSE: STVN) investors into whether the Company may have violated the federal securities laws. The investigation follows the November 3, 2026 disclosure regarding Stevanato Group S.p.A. Investors who lost m.

news source

Business Wire • Nov 4, 2026

news preview

Lost Money on Stevanato Group S.p.A. Shares? The Law Offices of Frank R.

LOS ANGELES--(BUSINESS WIRE)--Stevanato Group S.p.A. ("Stevanato" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Stevanato Group S.p.A. (NYSE: STVN), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Stevanato Group S.p.A. on November 3, 2026. If you lost.

news source

Business Wire • Nov 4, 2026

news preview

Stevanato Group S.p.A. (STVN) Q3 2026 Earnings Call Transcript

Stevanato Group S.p.A. ( STVN ) Q3 2026 Earnings Call November 3, 2026 8:30 AM EST Company Participants Lisa Miles - Chief Communications & Investor Relations Officer Franco Stevanato - CEO & Executive Chairman Marco Dal Lago - Chief Financial Officer Conference Call Participants David Windley - Jefferies LLC, Research Division Avantika Dhabaria - BofA Securities, Research Division Anna Snopkowski - KeyBanc Capital Markets Inc., Research Division Chad Wiatrowski - TD Cowen, Research Division Lawrence Solow - CJS Securities, Inc. Steven Etoch - Stephens Inc., Research Division Douglas Schenkel - UBS Investment Bank, Research Division Curtis Moiles - BNP Paribas, Research Division Albert Hu - Citigroup Inc., Research Division Justin Bowers - Deutsche Bank AG, Research Division Presentation Operator Good afternoon.

news source

Seeking Alpha • Nov 3, 2026

news preview

Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter of 2026. Third Quarter of 2026 Highlights (comparisons to prior-year period) Revenue increased 8% to €326.1 million, and on an organic basis* revenue increased 8%. Revenue from high-value solutions represente.

news source

Business Wire • Nov 3, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Stevanato Group S.p.A.

Open an M1 investment account to buy and sell Stevanato Group S.p.A. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in STVN on M1